Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.

There are 1,995 beds in UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN).

During the past decade, UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN)" #1 collaborator was "Andaluz Health Service" with 3 trials as a collaborator, "Atrys Health" with 3 trials as a collaborator, "August Pi Sunyer Biomedical Research Institute" with 3 trials as a collaborator, "Bayer" with 3 trials as a collaborator and "Centro Hospitalar do Porto" with 3 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN)" are "Psoriatic Arthritis" (2 trials), "Systemic Autoimmune Diseases" (2 trials) and "Healthy Subjects" (1 trials). Many other conditions were trialed in "UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN)" in a lesser frequency.

Most popular intervention types in "UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN)" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Tofacitinib" (1 trials), "Tofacitinib 10 mg BID" (1 trials) and "Tofacitinib 5 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN)" are 5 trials for "All" genders.

Currently, there are NaN active trials in "UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".